Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory ...

Pfizer says Canada has selected its "Abrysvo" RSV vaccine for use in adults 60 and over for the upcoming virus season. "Abrysvo" is also approved for use in pregnant people to provide protection to ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.

RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could ...

PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.

Here's what Canadians need to know: Older adults now have access to two approved vaccines, called Arexvy and Abrysvo.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

There's an RSV vaccine you can take when you're pregnant that will not only protect you but also your baby.[1]#1 The drug, known as Abrysvo and recommended for pregnant women by the Centers for ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...